About Max
This author has not written his bio yet.
But we are proud to say that Max contributed 868 entries already.
Entries by Max
Breakthrough in Cancer Immunotherapy: In Situ CAR-T Cell Generation Offers Hope for Lymphoma and Beyond
/in Immunotherapy, mRNA, Preclinical Research/by MaxA groundbreaking study led by Stanford Medicine, published in Cancer Immunology Research, has introduced a revolutionary approach to generating chimeric antigen receptor (CAR)-T cells directly inside the body, offering a promising new avenue for cancer treatment. This “in situ” method, which uses mRNA delivered via lipid nanoparticles (LNPs), successfully treated B-cell lymphoma in mice and […]
Newsletter 28/2025
/in Newsletter/by MaxLAST WEEK TODAY! A summary of what was published on ProstateWarriors.com during the past week Hi fellow warriors! More good news this week! I’d like to take this opportunity to ask you something: would you like me to include a link to the full article on ProstateWarriors.com in the newsletter? So far, I haven’t done it because […]
Newsletter 27/2025
/in Newsletter/by MaxLAST WEEK TODAY! A summary of what was published on ProstateWarriors.com during the past week Hi fellow warriors! This week has been a bit of a whirlwind, I’ve been working on my own research project. But we do have some interesting studies and a promising update!Stay strong and fight on! As usual, we also have a podcast […]
Project Navigator
Let's try to finance it!
A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.
Tags
Latest Posts
- Gallic Acid Targets a New Prostate Cancer Progression Pathway October 5, 2026
- Phase 3 Trial for 177Lu-ludotadipep Radioligand Therapy for mCRPC October 5, 2026
- Phase 2/3 Trial Will Test BAT Followed by Darolutamide October 5, 2026
- Phase 1/2 Trial: REGN21353 Plus Nezastomig STEAP1×CD3 and PSMA×CD28 Combination Enters mCRPC Trials October 5, 2026
